Abstract -Bisphenol A (BPA) is one of the most common endocrine disrupters. In the last decade, the number of studies concerning the effects of chronic treatment with BPA on the development of the central nervous system (CNS) has increased. However, little is known about the effects of chronic exposure to BPA on higher brain functions such as memory or psychomotor functions. Here, we report our following findings: (1) Prenatal and neonatal exposure to BPA enhances psychostimulant-induced rewarding effects, results in the up-or downregulation of dopamine receptors, causes memory impairment, and decreases choline acetyltransferase (ChAT) activity. (2) BPA activates astrocytes in vivo and in vitro. These findings suggest that prenatal and neonatal exposure to BPA affects the development of the CNS.
INTRODUCTION
Bisphenol A (BPA), one of the most common environmental endocrine disrupters, has been extensively evaluated for toxicity, including developmental and reproductive toxicity and carcinogenicity, through various tests in rodents. This compound is a monomer of polycarbonate plastics and is used for manufacturing epoxy resins (used for lining food and beverage cans) and dental sealants. Incomplete polymerization of the monomer causes BPA to easily leach out from the polycarbonate plastics and epoxy resins during heating of the cans or during contact with basic or acidic substances. There is increasing evidence that prenatal exposure to BPA affects the development of living animals. It has been reported that administration of BPA to pregnant mice at a dose that is within the range of the environmental levels that humans are typically exposed to causes remarkable changes in the postnatal growth rate and leads to early onset of puberty in these mice (Howdeshell et al., 1999) . Recently, it has been reported that prenatal exposure to BPA disrupts the brain sexual differentiation and sociosexual behaviors in rats (Kubo et al., 2001; Farabollini et al., 2002) . In this review article, we summarize the effects of prenatal exposure to BPA on the central nervous system (CNS). B0.002-B2) on methamphetamine (0.5 mg/kg, s.c.)-induced place preference. Methamphetamine-induced place preference or place aversion was not observed in mice that did not receive BPA exposure (BPA-untreated group; hatched bar). Mice belonging to the BPA-treated group (filled bar) showed a significant place preference when methamphetamine was administered at the abovementioned dose (*p＜0.05, **p＜0.01 vs. BPA-untreated group). Each column presents the mean ± standard error of mean (SEM) scores of place preference of 6-10 mice. (B) Effects of BPA (0.002-2 mg/g of food: B0.002-B2) on morphine (1 mg/kg, s.c.)-induced place preference. Mice in the BPA-untreated group (hatched bar) did not show any morphine-induced place preference or place aversion. Mice in the BPA-treated group (filled bar) showed a significant morphine-induced place preference when they were administered the abovementioned dose of morphine (*p＜0.05, **p＜0.01 vs. BPA-non treated group). Each column presents the mean ± SEM scores of place preference of 6-10 mice. digm is the most frequently used method to evaluate the motivational properties of drugs; further, when compared to the self-administration paradigm, this method has been reported to be frequently applied (Suzuki, 1996; Narita et al., 2001) . We reported that prenatal exposure to BPA induced hypersensitivity reactions in response to psychostimulants such as methamphetamine or morphine (Fig. 1A, B ) Mizuo et al., 2004a) . The enhancement of psychostimulant-induced rewarding effects after prenatal exposure to BPA was completely reversed by pretreatment with a dopamine D1 receptor antagonist, SCH23390 . We also showed that prenatal exposure to BPA resulted in upregulation of dopamine D 1 receptor signaling (Fig. 1C) . Moreover, we found that prenatal and neonatal exposure to BPA decreased the number of dopamine D 3 receptors and attenuated dopamine D3 receptor-mediated G-protein activation through the preferential dopamine D3 receptor agonist 7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) in the mouse limbic forebrain (Fig. 1D ) (Mizuo et al., 2004c) . The dopamine D3 receptor is widely distributed in the NAcc., the terminal site of the mesolimbic dopaminergic system (Sokoloff et al., 1990) . The selective expression of the dopamine D3 receptor in the limbic system has generated remarkable interest in this receptor as a potential mediator of some of the psychoactive effects of drugs on dopamine neurotransmission (Koob, 1992; Devoto et al., 1995; Levant, 1997; Koeltzow et al., 1998) . In addition, we have already reported that deletion of the central dopamine D3 receptor gene results in the enhancement of postsynaptic dopamine D 1 /D 2 receptor-mediated signaling, which in turn leads to the enhancement of morphine-induced rewarding effects and hyperlocomotion Mizuo et al., 2004b) . Our findings suggest that alteration in the functions of the dopaminergic system by prenatal and neonatal exposure to BPA is attributable to changes in the functions of the dopamine D 3 receptor. Many previous findings suggest that prenatal exposure to BPA affects the development of the monoaminergic system. Matsuda et al. (2010) reported that prenatal exposure to BPA alters the concentration of monoamines in the brain. In addition, Tian et al. (2010) showed that prenatal and neonatal exposure to BPA increases dopamine D2 receptor binding in the caudate putamen of mice. These results strongly support our findings that prenatal exposure to BPA affects dopamine-related behaviors.
Effects of low doses and importance of the duration of exposure to BPA It should be mentioned that the blood level of BPA in 2 mg/g of food group (approximately 10 ng/ml, data not shown) is considered to be more than 30 times higher than the level of BPA that a healthy human is exposed to (Inoue et al., 2000) . Because it is critical to elucidate the effects of low doses of BPA in order to evaluate its endocrine-disrupting activities, we investigated whether dopaminergic neurotransmission was affected by prenatal and neonatal exposure to BPA at levels below the lowest-observed-adverse-effect Level. We clearly observed enhancement of the morphine-induced rewarding effects by exposing mice to remarkably low concentrations of BPA ( Fig. 2A) . In addition, the dopamine-induced G-protein activation was also enhanced by prenatal and neonatal ex- posure to low doses of BPA. Taken together, these findings suggest that the hypersensitivity to morphine-induced pharmacological actions after prenatal and neonatal exposure to low and high doses of BPA may be attributable to the drastic upregulation of dopamine receptor functions in the limbic forebrain ( Fig. 2B) . Therefore, the present findings indicate that prenatal and neonatal exposure to not only high doses but also low doses of BPA may dramatically alter neuronal transmission, including dopaminergic transmission in the adult brain.
Exposure to BPA during either organogenesis or lactation significantly enhanced the morphine-induced rewarding effects (Fig. 3) (Narita et al., 2007) and resulted in the upregulation of dopamine receptor-induced G-protein activation in the mouse limbic forebrain (Narita et al., 2007) . In general, during organogenesis of the brain, particularly during cerebral development, it is well known that rapid proliferation, differentiation, or migration of the nerve cells and glial cells occur (Temple, 2001 ). In addition, the functional development of the CNS occurs most rapidly during lactation (Temple, 2001) . Therefore, these results strongly support our present results that organogenesis and lactation are the most sensitive periods during which BPA exposure influences the development of the CNS. Our findings suggest that exposure to BPA during organogenesis could affect differentiation or migration of neuronal stem cells. In addition, exposure to BPA during lactation affects the functional development of the CNS, including synaptogenesis and construction of the neuronal network.
Taken together, the present results may indicate that although BPA treatment of adult animals do not affect reproductive functions and social behaviors, exposure during the prenatal and neonatal stages, especially during organogenesis and lactation, induces toxicity in the developing neurons in the midbrain.
Development of dopaminergic neurons
Dopaminergic neurons in the mammalian brain have received substantial attention in the past, because they play a fundamental role in several body functions and behaviors. VTA cells modulate reward-related and cognitive behaviors, and their dysfunction is involved in the pathogenesis of addictive disorders and schizophrenia. The precise time of origin of the first postmitotic dopaminergic neurons is a topic of debate. It has become widely accepted that the first dopaminergic neuron originates around embryonic day (ED) 10.5 in mice (Riddle and Pollock, 2003; Smidt et al., 2003) . At this time, these cells express Nurr1, a member of the nuclear receptor family, and thus should be considered as postmitotic dopaminergic precursors, because these cells are not completely differentiated dopaminergic neurons (Wallen et al., 1999) . In a strict sense, when these precursors start expressing tyrosine hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis, these cells can be considered to be capable of synthesizing dopamine and thus considered as truly dopaminergic neurons. This occurs 1 day after the appearance of the precursor, i.e., at ED11.5, in mice (Wallen et al., 1999) . In mice, dopaminergic neurogenesis peaks around ED 12.5 during development and declines thereafter (Bayer et al., 1995; Marti et al., 2002) . Migration of the dopaminergic neurons to their final positions in the ventral mesencephalon and innervation in their target sites occur during the first postnatal weeks. In rats, this phase of dopaminergic neuronal development appears to be completed around the third postnatal week (Voorn et al., 1988) . At this time, the morphology and functionality of the dopaminergic system are identical to that observed in adults. We have shown that chronic treatment with BPA decreased the expression of dopamine D3 receptor, sonic hedgehog (Shh), and glial cell line-derived neurotrophic factor (GDNF) mRNAs in the entire brain obtained from the embryos of mice (ED14) (Miyagawa et al., 2007b) . However, no change in the expression levels of these mRNAs was noted in the adult mice after prenatal and neonatal exposure to BPA. Du et al. (2005) reported that dopamine D3 receptor-preferring agonists markedly increased the levels of GDNF Fig. 4 . Effects of prenatal and neonatal exposure to BPA on performance by using a step-through passive avoidance procedure. (A) At conditioning, the mice were placed in the light compartment of a two-compartment box and were administered a foot shock immediately after their entrance in the dark compartment. The step-through latency of the mice that received prenatal and neonatal exposure to low and high doses of BPA was similar to that of the control mice. (B) Prenatal and neonatal exposure to low and high doses of BPA induced significant memory impairment (Low: F(1,9) = 6.246, p＜0.05 vs. control; High: F(1,10) = 9.167, p＜0.05 vs. control). Each value represents mean ± SEM of 5-7 mice. A dramatical reduction in ChAT-like immunoreactivity (IR) but not NeuNlike IR in the hippocampus of the mice that received prenatal and neonatal exposure to low and high doses of BPA (Ci, Di, and Ei) was observed. In mice that received prenatal and neonatal exposure to low (Di) and high doses (Ei) of BPA, a dramatic decrease in the level of ChAT-IR was noted in the hippocampus, when compared with the control (Ci). Images of high magnification show ChAT-IR in the dentate gyrus (DG). In the mice that received low (Dii) and high doses (Eii) of prenatal and neonatal exposure to BPA, ChAT-IR was dramatically decreased in the DG, when compared with the control (Cii). On the other hand, in mice exposed to prenatal and neonatal exposure to low (Diii) and high doses (Eiii) of BPA, NeuN-IR in the DG remained unaffected, when compared with the control mice (Aiii). DG: dentate gyrus. Scale bars: 50 μm. and brain-derived neurotrophic factor (BDNF) in mesencephalic cultures with a conditioned medium; this resulted in an increase in the number of dopaminergic neurons. GDNF is an important neurotrophic factor for the regulation of the development and for the survival of the midbrain dopaminergic neurons (Lin et al., 1993; Kholodilov et al., 2004) . Shh and fibroblast growth factor-8 (FGF-8) have been reported to direct the differentiation of progenitor cells into midbrain dopaminergic neurons (Lee et al., 2000) . Shh also plays an important role in dopaminergic axon pathfinding to rostral targets (Hammond et al., 2009) Therefore, the present results support the idea that prenatal and neonatal exposure to BPA may disrupt dopaminergic neuronal development that is associated with Shh and GDNF expressions.
MEMORY IMPAIRMENT OWING TO PRENATAL EXPOSURE TO BPA
Because the site of action of BPA remains unknown, it is most likely that prenatal and neonatal exposure to BPA induces other behavioral abnormalities associated with the alteration of not only the dopaminergic system but also other neurotransmissions. We investigated the influence of prenatal and neonatal exposure to BPA on memory proc-esses in mice by using the step-through passive avoidance test. In the conditioning trial, the step-through latency of the mice exposed to low and high doses of BPA during the prenatal and neonatal stages was similar to that of the control mice (Fig. 4A) (Miyagawa et al., 2007a) . Although the step-through latency increased among all the groups as compared to that at conditioning, the latencies of mice that were exposed to BPA during the prenatal and neonatal stages to step into the dark compartment dramatically decreased as compared to those of the control mice. (Fig. 4B) (Miyagawa et al., 2007a) . These results strongly suggest that chronic treatment with low and high doses of BPA resulted in memory impairment. Contextual fear conditioning is a hippocampal-dependent memory. Therefore, we subsequently investigated the morphological and/or functional changes in the hippocampus of mice that received prenatal and neonatal exposure to low and high doses of BPA.
Our immunohistochemical examination revealed that in mice that received prenatal and neonatal exposure to low and high doses of BPA, the level of choline acetyltransferase-like immunoreactivity (ChAT-IR) in many regions of the hippocampus dramatically decreased, when compared with the control (Fig. 4Ci-4Ei) (Miyagawa et al., 2007a) . In particular, as shown in highly magnified images (Fig.  4Cii-4Eii) , the density of the cholinergic fiber was dramatically decreased in mice that received prenatal and neonatal exposure to low and high doses of BPA, when compared with the control (Miyagawa et al., 2007a) . It is widely accepted that cholinergic function in the hippocampus is important for learning and memory processes (Bartus et al., 1982; Miyamoto et al., 1987; Dutar et al., 1995) . These results strongly support our findings that memory impairment remarkably corresponded to dysfunction of the cholinergic neurons in the hippocampus of mice that received prenatal and neonatal exposure to BPA. On the other hand, in mice that received prenatal and neonatal exposure to BPA, the levels of the neuron-specific nuclear protein (NeuN)-IR in the dentate gyrus (Miyagawa et al., 2007a) and in other regions of the hippocampus remained unaffected, when compared with the control; this finding indicates that prenatal and neonatal exposure to BPA does not result in cell death or layer formation on the mature pyramidal or granular cells in the hippocampus.
ACTIVATION OF ASTROCYTES BY BPA
There is increasing evidence that astrocytes are important modulators of synaptic transmission. Astrocytes can respond to neurotransmitters released within the synaptic cleft by increasing intracellular Ca 2+ concentration and releasing glutamate and/or ATP that are signaled back to the neurons (Haydon, 2001; Fellin and Carmignoto, 2004) . Therefore, it is worthwhile to determine the effects of BPA on astrocytes. We showed that in vitro treatment with BPA caused morphological changes in glial fibrillary acidic protein (GFAP)-positive astrocytes. (Fig. 5) (Miyatake et al., 2006) In addition, this effect of BPA was biphasic: treatment with 1 pM or 1 μM of BPA resulted in robust activation of the astrocytes, whereas treatment with 1 nM of BPA did not have any detectable effects on the morphology of the astrocytes. Treatment with a high concentration of BPA induced marked neuronal cell death in the midbrain neurons/glia cocultures. Thus, these results suggest that a high concentration of BPA may cause dynamic changes in the neuronal-glial network and thus result in neurotoxicity.
Neurons and astrocytes respond to various chemical stimuli, including neurotransmitters, neuromodulators, and hormones, which result in an increase in the intracellular Ca 2+ concentration. These Ca 2+ responses result from the coordinated activity of several molecular cascades that are involved in the movement of Ca 2+ into or out of the cytoplasm from extracellular spaces or intracellular stores, respectively. We reported that treatment with BPA significantly enhanced the dopamine-induced Ca 2+ responses in mixed cultures of neurons and astrocytes (Miyatake et al., 2006) . These results strongly support the idea that the enhancement of dopamine-induced Ca 2+ responses after exposure to BPA could lead to an increase in the excitability of the central dopaminergic neurons. It has been reported that stimulation of dopamine D1 receptor increases intracellular Ca 2+ concentration via activation of phospholipase C-inositol-1,4,5-trisphosphate signaling pathway (Pacheco and Jope, 1997; Jin et al., 2003) . Dopamine-induced Ca 2+ responses are also modulated by dopamine D2 receptor (Zhu et al., 1997; Takeuchi et al., 2002) . On the other hand, dopamine D3 receptor usually coexists with dopamine D 1 and D 2 receptors (Surmeier et al., 1992; Schwartz et al., 1998) and contributes to the inhibitory effects of dopamine D1 and/or D2 receptor-mediated signaling (Mizuo et al., 2004b) . Thus, the present results suggest that treatment with 1 pM of BPA may enhance dopamine D1 receptor function and/or attenuate dopamine D 3 receptor function, resulting in enhancement of the dopamine-induced Ca 2+ responses in neurons and astrocytes.
MECHANISMS OF BPA
With regard to the possible mechanisms of action of BPA, it has been reported that BPA has estrogenic activity. The results of recent molecular studies suggest that endogenous estrogen is important for the development of the mammalian brain. It has been suggested estrogen activates transcription of the human dopamine D1 receptor gene (Lee and Mouradian, 1999) . It can be proposed that upregulation of dopamine D 1 receptor after prenatal and neonatal exposure to BPA may result from tonic stimulation of estrogen receptors. These findings suggest that the primary action of BPA is to probably mimic or inhibit the endogenous hormone receptor-mediated action, including estrogen receptor-mediated action. Recently, researchers engaged in molecular studies proposed the rapid signaling of BPA. The rapid signaling of BPA is distinguished from nuclear hormone receptor-mediated transactivation activity that induces gene expression. This rapid signaling pathway can be explained by the involvement of an alternative seven-transmembrane G-protein coupled receptor. GPR30, a G-protein coupled estrogen receptor located in the plasma membrane, is one of the candidate receptors for the rapid signaling of BPA. GPR30 is highly expressed in the hypothalamus, hippocampus, brainstem, and striatum (Brailoiu et al., 2007 neurons and glia that were cocultured and in purified astrocytes (Miyatake et al., 2006) . Although a detailed mechanism remains to be elucidated, it can be stated that the signaling pathway of GPR30 may, at least in part, contribute to the rapid signaling of BPA. On the other hand, it was confirmed that BPA exhibited weak estrogenicity; the potency of BPA is approximately 15,000 times lesser than that of 17β-estradiol (Gaido et al., 1997) . Furthermore, BPA binds to estrogen receptors with a low affinity and transactivates the estrogen responsive element-driven reporter gene in vitro (Gaido et al., 1997) . We found that antagonists of estrogen receptor, progesterone receptor, and androgen receptor did not have any effect on the BPA-induced activation of astrocytes. Furthermore, treatment with estradiol (E2) did not activate either purified astrocytes or neurons and glia that were cocultured. We also found that prenatal and postnatal exposure to E2 failed to enhance the rewarding effects of morphine in mice. These results suggest that estrogen is not essential for the enhancement of dopaminergic neurotransmission and the BPA-induced hypersensitivity to morphine-induced rewarding effects.
Some of the other mechanisms for BPA have been proposed. BPA has been reported to act as an antagonist of thyroid receptors (Moriyama et al., 2002) . It is widely known that thyroid hormones are essential for brain development. In addition, Song et al. (2002) reported that BPA induces the orphan nuclear receptor Nur77 gene expression and is involved in steroidogenesis in the Leydig cells of mice. Several subfamilies of Nur77, for example, NGFI-B or Nurr1, have been shown to be highly expressed in the brain (Xiao et al., 1996) . In particular, it has been accepted that NGFI-B is highly expressed in the basal ganglia and is involved in the development of dopaminergic and opioidergic systems (Zetterstrom et al., 1996) .
Several findings indicate that BPA induces oxidative stress in many organs (Bindhumol et al., 2003; Kabuto et al., 2003) . BPA facilitates the production of reactive oxygen species (ROS) and thus results in neuronal damage (Ooe et al., 2005; Lee et al., 2008) . Moreover, BPA and some bisphenols have been reported to cause a reduction in mitochondrial functions (Nakagawa and Tayama, 2000) . It is widely accepted that during development, neurons are highly sensitive to ROS. Although further studies are needed to clarify the effects of BPA on the developmental processes, the findings of these reports suggest that oxidative stress may contribute to the action of BPA.
Finally, the findings of recent studies suggest that BPA appears to induce physiological responses such as DNA methylation via epigenetic mechanisms (Ho et al., 2006; Dolinoy et al., 2007; Yaoi et al., 2008; Baccarelli and Bollati, 2009; Bromer et al., 2010) . Ho et al. (2006) reported that neonatal exposure to BPA increases phosphodiesterase-4 expression, which results from early and increased DNA hypomethylation. Yaoi et al. (2008) showed that exposure to low doses of BPA alters DNA methylation in the forebrain of a mouse fetus. Taken together, these findings suggest that although we cannot completely exclude the possibility of the estrogenic action of BPA, the action of BPA that is currently known may mainly be attributable to novel mechanisms underlying dopaminergic transmission.
CONCLUSION
In this review article, we provide evidences to support the idea that prenatal and neonatal exposure to various concentrations of BPA could affect various stages of neuronal development. Research regarding the biological effects of BPA has tremendously progressed in the last decade. We hope that the findings of these studies will elucidate the complete mechanisms of BPA in the future.
